Skip to content

Effectiveness of Thoracoabdominal Nerve Block (M-TAPA) on Postoperative Pain Relief in Laparoscopic Hysterectomy

Effectiveness of Modified-Thoracoabdominal Nerve Block With Perichondrial Approach (M-TAPA) on Postoperative Pain Relief in Laparoscopic Hysterectomy Surgery: A Prospective, Randomized, Double-Blind, Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07483190
Enrollment
60
Registered
2026-03-19
Start date
2026-06-09
Completion date
2026-11-15
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysterectomy, Plane Blocks, Postoperative Pain

Brief summary

This study aims to investigate the effectiveness of a specific regional anesthesia technique, the Modified-Thoracoabdominal Nerve Block through a Perichondrial Approach (M-TAPA), on reducing pain after laparoscopic hysterectomy surgery. Hysterectomy is a common major surgical procedure, and managing postoperative pain is crucial for patient comfort and faster recovery. Participants will be randomly assigned to one of two groups: The M-TAPA Group: Patients will receive the nerve block using a local anesthetic (bupivacaine) before the surgery begins. The Control Group: Patients will receive standard postoperative pain management without the nerve block. The primary goal is to determine if the M-TAPA block reduces the total amount of opioid (morphine) used by patients in the first 24 hours after surgery. The researchers will also evaluate pain scores (NRS), the time until the first request for additional pain medication, patient satisfaction, and any side effects like nausea or vomiting

Interventions

PROCEDUREModified-Thoracoabdominal Nerve Block through a Perichondrial Approach (M-TAPA)

Under ultrasound guidance, a 22-gauge peripheral block needle is inserted at the costochondral angle (9th-10th ribs). After confirming the position, 20 ml of 0.25% bupivacaine is injected bilaterally into the lower part of the chondrium.

Sponsors

Istinye University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 and 70 years * ASA (American Society of Anesthesiologists) physical status I, II, or III * Scheduled for elective laparoscopic hysterectomy * Voluntary participation with signed informed consent

Exclusion criteria

* Hepatic or renal disease. * Coagulation disorders. * Uncontrolled cardiovascular or respiratory diseases. * Psychiatric disorders. * History of allergy to local anesthetics. * History of alcoholism, drug or substance abuse. * Body Mass Index (BMI) greater than 35 kg/m2 * Refusal of the regional block procedure

Design outcomes

Primary

MeasureTime frameDescription
Morphine consumptionFirst 24 hours postoperativelyTotal amount of morphine (mg) used via Patient-Controlled Analgesia (PCA)

Secondary

MeasureTime frameDescription
Postoperative Pain Scores (NRS)Baseline (Hour 0), 1, 2, 4, 6, 12, and 24 hours postoperativelyNumerical Rating Scale (0=no pain, 10=worst pain)
Rescue analgesic drug consumptionWithin the first 24 hours postoperativelyThe amount of rescue analgesic in mg required by the patient will be recorded for the first 24 hours.
Incidence of postoperative nausea and vomitingWithin the first 24 hours postoperativelyNumber of patients developing postoperative nausea and vomiting will be recorded for the first 24 hours

Countries

Turkey (Türkiye)

Contacts

CONTACTonur senyurt
senyurtonur@yahoo.com+905520265992

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026